ASH/ Smoking & health/ Impotence |
|
Smoking and Male Sexual Problems
Summary
Mechanisms of Erectile Dysfunction
Evidence
Views of Specialists
What Should Be Done
Appendix 1
Appendix 2
View the press release
Send a virtual Postcard
Smoking and Erectile Dysfunction in Men
Terms |
|
|
|
|
|
|
|
| Mechanisms of Penile Erectile Dysfunction | ![]() |
Other impacts |
The damage caused by smoking to male sexual health also includes:
|
Smoking is a major and avoidable hazard for
sexual health. Given that two of the three main side effects of smoking on erectile
function are acute responses to nicotine, then immediate improvements on stopping smoking
are possible. |
|
Polling undertaken by MORI for ASH in March 1999 reveals that only 12% of smokers (13% men, 11% women) name smoking as a cause of male impotence. |
|
Labels on cigarette packs and other tobacco
products should contain warnings about the threat to men's sexual health. A new
European Union Directive will soon replace the existing Directive (89/622/EEC) which
specifies the current warnings. Cigarettes sold in Thailand now carry impotence warnings,
and the idea is also under consideration in Hong Kong. |
|
New warnings on packs |
The following warnings should be added to approved list of warnings that can be specified in the new Directive: |
WARNING: SMOKING CAUSES MALE SEXUAL IMPOTENCEWARNING: SMOKING DAMAGES SPERM WARNING: SMOKING MAY DAMAGE YOUR SEX-LIFE |
Part 1. Evidence
Impotence defined |
Impotence, or penile
erectile dysfunction, is the consistent or recurrent inability to attain and maintain an
erection. Studies suggest that around 74% of all cases are attributable to physical
causes.1
|
|
| A major study in the
US found that one in every 13 US men between 20 and 39 is impotent. This number increases
with age to roughly 1 in 10 men across the whole adult population.2 - that's
the equivalent of two million men in the UK alone.3
|
||
| Impotence is
associated with a range of conditions including high cholesterol levels, drugs used to
treat high blood pressure and diabetes, however there is strong evidence to demonstrate
that the effects of all physical factors are made worse by smoking.4
|
||
| Circulatory or
vascular problems are the most common physical cause of impotence. These affect the normal
flow if blood into and out of the penis, resulting in lowered blood pressure in the penile
arteries. Smoking inhibits sexual function in three ways:
|
||
|
||
|
||
| Cigarette smoke
contains some 4,000 chemicals. Several of these are implicated in damage to the vascular
(circulatory) system, including carbon monoxide, nicotine11 and 1,3-butadiene12.
The ultimate consequence of this is a toll of 40,300 premature deaths every year in the UK
due to heart and circulation diseases.13 Damage to the arteries and veins
supplying the penis, is simply a manifestation of systemic arterial damage.
|
||
| Evidence suggests
that cigarette smoking significantly increases other risk factors for impotence. A study
of 1,290 men who had received treatment for impotence in Massachusetts, USA14,
showed that smokers were over twice as likely to become impotent as non-smokers - 56%
compared with 21%. Cigarette smoking was also associated with a significantly greater
likelihood of complete impotence in men with high blood pressure (hypertension), heart
disease and arthritis. Smoking does not therefore, merely add to other risk factors, but
compounds them.15
|
||
| There is compelling
evidence to suggest impotence indicates more serious underlying vascular problems. Damage
to the small blood vessels of the penis manifested as erectile dysfunction may offer an
early warning signal that a smoker is risking serious damage to the main arteries in the
heart. In this way the penis is acting as a 'canary', signaling a more serious
threat to the heart and general circulatory system.
|
||
| There are various
estimates of the relative risk of impotence among smokers and non-smokers. A study of
4,462 Vietnam War veterans between the ages of 31 and 49 showed an 80% increase in the
risk of impotence among smokers compared with men who had never smoked.16 Even
when adjusted for several other confounding factors,17 the findings showed a
50% increased risk.
|
||
| Among 178 patients
attending an impotence clinic in the USA, the number of current smokers and ex-smokers
(82%) was significantly higher than would be expected among men in the general population
(58%).18 In each group, and at all levels of tobacco use, impotent patients
smoked more then would have been expected from population estimates. Only 19% of these
patients had never smoked compared with 42% in the general population. The same study showed that the average PBI was lower among patients who had smoked than among those who had not. A significantly higher proportion (20.9%) of impotent patients with a history of smoking had abnormally low BPI compared with patients who had never smoked. The findings also suggested an association between length of smoking habit and abnormally low BPI.
|
||
| On the basis of the
increased risk faced by smokers, the known rates of smoking among men, and reported levels
of impotence in the UK, ASH and the BMA estimate that around 120,000 UK men in their 30s
and 40s are needlessly impotent as a result of smoking. Although both smokers and
non-smokers can become impotent, these represent additional cases directly attributable to
smoking and no other cause. The calculation is outlined in Appendix 1: Calculation of
smoking attributable impotence.
|
||
| A poll commissioned
by ASH and undertaken by MORI in March 1999 shows a low level of awareness of the risk of
impotence arising from smoking.19 The survey shows that a substantial 88%
majority of smokers (87% of men and 89% of women) do not name smoking as a cause of
impotence. Even when prompted with a list of possible factors including smoking, over
two-thirds (67%) do not identify smoking as a risk (65% of men and 70% of women). ASH and the BMA believe that the low level of awareness among smokers makes a compelling case for new warnings on packets of cigarettes and other tobacco products.
|
||
| Medical research
links smoking with other areas of male sexual health, including reduced volume of
ejaculate, lowered sperm count, abnormal sperm shape and impaired sperm motility20,21,22.
Smoking is also linked to pyospermia, a condition manifested in swollen testes with excess
white blood cells (pus) present in ejaculate.23 |
Part 2: Views of specialists
Part 3: What should be done?
Impotence warnings on cigarette packs |
ASH and the BMA call for the British Government and the European Union to add the following warnings to labels on cigarettes and tobacco products sold in the UK and EU: |
| WARNING: SMOKING CAUSES MALE SEXUAL IMPOTENCE WARNING: SMOKING DAMAGES SPERM WARNING: SMOKING MAY DAMAGE YOUR SEX-LIFE
|
Legislative approach to new warnings |
The warnings that can
be used on packs throughout the EU are specified in EU Directive 89/622/EEC (as amended
by 92/41/EEC).
Following a Council of Ministers declaration on 4th December 1997, indicating a
desire among Member States to see a strengthening of policy in this area, the European
Commission is currently preparing proposals for a new Directive. The proposal is expected
within the next few months. The existing Directive (92/41/EEC Annex 1) contains a list26
of health warnings which either have to be included (Annex 1A), or may be included (Annex
1B) in the lists of warnings required by Member States (see Appendix 2: Existing
warnings on cigarette packs in the EU.) In order for the warnings above to be included
on cigarettes sold in the UK, they would need to be added to the Annex -- assuming the
new Directive retains a structure similar to the existing Directive. In the UK, the EU Directive is implemented through the Tobacco Products Labeling (Safety) Regulations 1991.27 These would be amended following the introduction of the new Directive.
|
Appendix 1: Calculation of smoking attributable impotence
The variables and formula below are used to make the estimate
20-39 |
40-49 | |||
| Number of men | 8,930,000 | 3,980,000 | ||
| Share with Impotence | 7.4% | 11% | ||
| Number with Impotence | 669,750 | 437,800 |
A calculation and interpolation of the figures above suggest that 838,500 30 to 49
year-old
UK men suffer from impotence.
The variable and formula below can be used to make an estimate
Pc(30-49) |
34% |
Proportion of male smokers 30-49 |
Rc |
1.5 |
Relative impotence risk for smokers |
Pf |
32% |
Proportion of male ex-smokers |
Rf |
1.0 |
Relative impotence risk for ex-smokers |
a |
14.5% |
Attributable fraction a=[Pc(Rc-1)+Pf(Rf-1)]/[1+Pc(Rc-1)+Pf(Rf-1)] |
Ni |
838,500 |
Men with impotence 30-49 |
Ns |
121,833 |
Impotence cases attributable to smoking: Ns = aNi |
| The methodology used is identical to that applied by Callum to estimate the death toll from smoking related diseases in the UK.28 The calculation is based on the following premises: | |
| * | The age distribution of impotence sufferers is 7.4% for 20-39 year olds and 11% for 40-49 year olds29 |
| * | The relative risk of impotence for smokers is 1.5 |
| * | The proportion of smokers in the male population is 29%30 |
| * | No excess risk has been attributed to ex-smokers on account of their smoking behaviour. Though full or partial recovery is possible, this assumption must be regarded as optimistic, and therefore the total burden of smoking related impotence is likely to be greater than the figure suggested above. |
| * | No estimate has been made of smoking attributable impotence in under 30s or over 50s. |
| * | Population data from the Office of National Statistics.31 |
Appendix 2: Existing warnings on cigarette packs in the EU
The following list is from Annex 1 of EU Directive 92/41/EEC. Those displayed in
bold are in current 1999 use in the UK.
Notes and References
|